End-to-End CGT Bioprocess Platform Solutions
Cell and gene therapies are revolutionizing modern medicine, while manufacturing complexity and scaling hurdles hinder industrialization. LePure Biotech offers an integrated, GMP-compliant CGT bioprocess platform. We serve plasmid, viral vector, immune cell and stem cell, covering upstream culture, downstream purification and final fill-finish.
Backed by self-developed single-use system and validated workflows, our modular solutions ensure scalable, cost-effective and consistent production. We help clients accelerate progress from preclinical research to commercial manufacturing.
Contact UsCore Competitive Advantages
- Full-industry Chain Coverage: One-stop solutions covering plasmids, viral vectors, immune cells and stem cells.
- IP Compliance Assurance: Authorized HEK293 cell line resources to eliminate global commercialization barriers.
- Verified Scalable Workflow: Mature single-use systems enabling seamless scale-up from lab to commercial scale.
- Secure Localized Supply Chain: Independent manufacturing system ensures stable delivery and batch consistency..
Download Gene and Cell Therapy Handbook
We provide an integrated process platform for AAV and lentiviral vector manufacturing, with single-use solutions supporting key process steps from plasmid preparation and upstream cell culture to downstream purification, formulation, and filling.
